Technical Analysis for NVTA - Invitae Corporation

Grade Last Price % Change Price Change
grade A 44.67 4.59% 1.96
NVTA closed up 4.59 percent on Friday, September 25, 2020, on approximately normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical NVTA trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
New 52 Week High Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
180 Bullish Setup Bullish Swing Setup 4.59%
Slingshot Bullish Bullish Swing Setup 4.59%
Multiple of Ten Bullish Other 4.59%
Wide Bands Range Expansion 4.59%
Overbought Stochastic Strength 4.59%
New 52 Week High Strength 9.62%
Older End-of-Day Gignals for NVTA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Trending on StockTwits about 12 hours ago
New 52 Week High about 18 hours ago
1.5x Volume Pace about 18 hours ago
Up 3% about 18 hours ago
Upper Bollinger Band Resistance about 18 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Invitae Corporation processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for physicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. The company's product is an assay of 216 genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, and other hereditary conditions comprising 85 various genetic disorders and 17 targeted panels. It also solutions that enable sharing of genetic information consisting of Invitae Family History Tool, a Web or iPad application, which provides family history; and Clinvitae, a Web property that allows physicians or patients to look up individual genes and variants in order to find out additional genetic information. It operates in the United States, Israel, and internationally. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Medicine Cancer Biology Telemedicine Telehealth Genetics Medical Genetics Medical Tests Neurological Disorders Molecular Diagnostics Software Tools Genetic Disorders Neurology Cardiovascular Disorders Genetic Disorder

Is NVTA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 44.82
52 Week Low 7.415
Average Volume 2,585,364
200-Day Moving Average 22.59
50-Day Moving Average 33.78
20-Day Moving Average 37.13
10-Day Moving Average 40.51
Average True Range 2.91
ADX 31.42
+DI 29.53
-DI 12.51
Chandelier Exit (Long, 3 ATRs ) 36.08
Chandelier Exit (Short, 3 ATRs ) 37.94
Upper Bollinger Band 45.28
Lower Bollinger Band 28.98
Percent B (%b) 0.96
BandWidth 43.89
MACD Line 2.80
MACD Signal Line 2.06
MACD Histogram 0.739
Fundamentals Value
Market Cap 1.95 Billion
Num Shares 43.5 Million
EPS -2.73
Price-to-Earnings (P/E) Ratio -16.36
Price-to-Sales 9.34
Price-to-Book 5.59
PEG Ratio -0.46
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 48.21
Resistance 3 (R3) 47.87 46.34 47.62
Resistance 2 (R2) 46.34 45.44 46.52 47.42
Resistance 1 (R1) 45.51 44.88 45.93 45.85 47.23
Pivot Point 43.98 43.98 44.19 44.16 43.98
Support 1 (S1) 43.15 43.08 43.57 43.49 42.11
Support 2 (S2) 41.62 42.52 41.80 41.92
Support 3 (S3) 40.79 41.62 41.72
Support 4 (S4) 41.13